Trial Profile

A Phase 1b/2a, Open-Label, Multi-Center Study of AV-951 in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tivozanib (Primary) ; Paclitaxel
Indications Advanced breast cancer
Focus Adverse reactions; Pharmacogenomic; Therapeutic Use

Most Recent Events

30 Jun 2012 The Phase 2a study portion of the study was not conducted.
08 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
19 May 2011 Phase I results will be presented at the Annual Meeting of the American Society of Oncology (ASCO-2011).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com